Pfizer-Backed VitaDAO Launches Biotech Firm

Hi NoRamp Community,

Proof of Work Podcast:

NoRamp chatted with Vercel’s CTO, Malte Ubl:

Daily News:

Sam Altman Talks US Gov’t Crypto Clash on Joe Rogan

Crypto Investment Inflows Hit Multi-Month High of $78M

Pfizer-backed VitaDAO Launches Biotech Firm

Sam Altman Discusses US Gov’t & Crypto:

• OpenAI CEO, Sam Altman, expressed concern over the US government's increasing attempts to regulate crypto, likening it to waging a "war" on the sector during a podcast with Joe Rogan.

• Altman acknowledges the need for some crypto regulation but warns against hastily crafted restrictions that might hinder the industry's innovation, especially in reaction to specific incidents like the FTX collapse.

• Despite acknowledging the potential of Bitcoin as a global currency, Altman emphasizes the need for a balanced regulatory approach, highlighting the tension between the crypto community and cautious regulators.

Crypto Investment Inflows Hit Multi-Month High:

• Crypto investment witnessed a surge with a $78 million inflow over the past week, the highest since July, driven by a 37% jump in crypto ETP volumes to $1.1 billion. Bitcoin activity on exchanges also increased by 16%.

• Solana saw significant altcoin interest, but new US Ethereum futures ETFs only garnered $10 million in the initial week. Europe dominated the inflows, with Germany and Switzerland contributing 88% combined.

• The increasing European interest in crypto investments underscores the region's pivotal role, driven by crypto-friendly regulations in countries like Germany and Switzerland. This could prompt other regions to adopt similar frameworks to boost institutional investment.

Pfizer-Backed VitaDAO Launches Biotech Firm:

• VitaDAO, a decentralized organization focused on longevity research, has founded a biotech company named Matrix Biosciences. This venture, in collaboration with famed biologist Vera Gorbunova, will explore advanced treatments for cancer and age-related diseases, drawing inspiration from the cancer-resistant traits of the naked mole-rat.

• While VitaDAO operates on a decentralized model, Matrix Biosciences will function as a centralized entity, with VitaDAO being its primary shareholder. The venture seeks to bridge the gap between blockchain technology and the biotech industry, ensuring compliance with medical and healthcare regulations.

• Matrix Biosciences aims to delve deep into the study of the naked mole-rat, which possesses a compound known for its anti-cancer and longevity properties. The objective is to harness this potential for human treatments. VitaDAO will fund Matrix Biosciences with an initial $300,000, supplemented later by its IP-NFT fractionalization model.

NoRamp:

NoRamp is building Web2’s favorite Web3 apps on our lightning-fast payment infra. Join our discord, dive into our our docs, or check out our website to learn more.

If you’ve read this far and haven’t yet subscribed, you probably should here.